Citations (2)
Keep up to date with the latest research on this topic with citation updates for this article.
Report
Enhanced immunogenic potential of cancer immunotherapy antibodies in human IgG1 transgenic mice
Jerome Eglia Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
https://orcid.org/0000-0002-0781-0773View further author information
https://orcid.org/0000-0002-0781-0773View further author information, , , , , , , , Gregor P. Lotzc Roche Pharma Research and Early Development, Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, Germanyhttps://orcid.org/0000-0002-0231-5503View further author information
https://orcid.org/0000-0002-0231-5503View further author information, , Thomas E. Kraftc Roche Pharma Research and Early Development, Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, Germanyhttps://orcid.org/0000-0002-5528-3197View further author information
https://orcid.org/0000-0002-5528-3197View further author information, , , , , Daniela Finked Department of Biomedicine and University Children’s Hospital of Basel, University of Basel, Basel, Switzerlandhttps://orcid.org/0000-0003-4453-5958View further author information
https://orcid.org/0000-0003-4453-5958View further author information, Juliana Bessaa Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, SwitzerlandCorrespondence[email protected]
https://orcid.org/0000-0001-6730-3792View further author information
https://orcid.org/0000-0001-6730-3792View further author information & show all